Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewMOMBA is a selective orthosteric agonist for human free fatty acid 2 (hFFA2) engineered receptors, designer receptors activated by designer drugs (DREADD), it shows no activity to wild-type hFFA2, hFFA3, and mouse FFA2. MOMBA inhibit forskolin-stimulated cAMP levels in cells expressing the hFFA2-DREADD receptor with improved potency and equivalent efficacy to Sorbic acid (Cat. No. 7119). In hFFA2-DREADD transgenic mice, MOMBA treatment significantly reduces gut transit and promotes concentration-dependent release of GLP-1 from colonic crypts. Orally bioavailable.
M. Wt | 166.17 |
Formula | C9H10O3 |
Storage | Store at -20°C |
Purity | ≥98% (HPLC) |
CAS Number | 6880-04-2 |
PubChem ID | 2759583 |
InChI Key | DNMUMZLKDOZMEY-UHFFFAOYSA-N |
Smiles | O=C(O)C1=CC=C(OC)C(=C1)C |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solvent | Max Conc. mg/mL | Max Conc. mM | |
---|---|---|---|
Solubility | |||
DMSO | 16.62 | 100 | |
ethanol | 16.62 | 100 |
The following data is based on the product molecular weight 166.17. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 6.02 mL | 30.09 mL | 60.18 mL |
5 mM | 1.2 mL | 6.02 mL | 12.04 mL |
10 mM | 0.6 mL | 3.01 mL | 6.02 mL |
50 mM | 0.12 mL | 0.6 mL | 1.2 mL |
References are publications that support the biological activity of the product.
Barki et al (2022) Chemogenetics defines a short-chain fatty acid receptor gut-brain axis. Elife 11 e73777 PMID: 35229717
Miura et al (2022) Chemogenetics of cell surface receptors: beyond genetic and pharmacological approaches. RSC Chem.Biol. 3 269 PMID: 35359495
Milligan et al (2021) Chemogenetic approaches to explore the functions of free fatty acid receptor 2. Trends Pharmacol.Sci. 42 191 PMID: 33495026
If you know of a relevant reference for MOMBA, please let us know.
Keywords: MOMBA, MOMBA supplier, orthostatic, agonist, free, fatty, acid, receptor, 2, FFA2, hFFA2, designer, receptors, activated, by, drugs, DREADD, DREADDs, Free, Fatty, Acid, Receptors, 7926, Tocris Bioscience
Citations are publications that use Tocris products.
Currently there are no citations for MOMBA. Do you know of a great paper that uses MOMBA from Tocris? Please let us know.
There are currently no reviews for this product. Be the first to review MOMBA and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Produced by Tocris, the chemogenetics research bulletin provides an introduction to chemogenetic methods to manipulate neuronal activity. It outlines the development of RASSLs, DREADDs and PSAMs, and the use of chemogenetic compounds. DREADD ligands and PSEMs available from Tocris are highlighted.
GPCRs can interact with multiple distinct transducers or regulatory proteins and these can be preferentially engaged in an agonist-specific manner giving rise to biased agonism. This poster discusses cutting edge GPCR signaling pharmacology and highlights therapeutic applications of biased agonism.